Drug Profile
Interferon beta-1a biosimilar - Biocad
Alternative Names: BCD-033; interferon β1a - Biocad; TeberifLatest Information Update: 07 Jun 2023
Price :
$50
*
At a glance
- Originator Biocad
- Class Antiasthmatics; Antineoplastics; Antivirals; Interferons; Vascular disorder therapies
- Mechanism of Action Immunostimulants; Interferon beta-1a replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Multiple sclerosis